Industry & Business

Dublin startup scores €85 million funding for new approach to cancer therapy

 Breaking News
  • Research Reveals SMEs Lose €2.2 Billion a Year in Productivity Due to Administration Sage, a market leader in cloud accounting software, has revealed that Irish SMEs lose up to €2.2 billion annually in productivity due to burdensome administrative tasks. The report, ‘Sweating the Small Stuff: the impact of the bureaucracy burden’, undertaken by Plum Consulting, shows businesses in Ireland spend an average of 70 working-days per year navigating the [...]...
  • European Commission Takes Action For a More Competitive and Innovative Financial Market The European Commission has unveiled an Action Plan on how to harness the opportunities presented by technology-enabled innovation in financial services (FinTech). Europe should become a global hub for FinTech, with EU businesses and investors able to make most of the advantages offered by the Single Market in this fast-moving sector. As a first major deliverable, [...]...
  • 40% Think Irish Government Not Doing Enough to Protect Ireland From Impact of Brexit Brexit is coming closer and still a lot of questions remain unanswered. People are insecure not only about their own future but also the economic future of Ireland. iReach Insights conducted a nationally representative survey and 1,000 adults were asked about their opinion about the Brexit, it’s potential impact and what Irish people would do, [...]...
  • Guinness Remains Ireland’s Most Valuable Brand at €2.1 Billion Guinness remains Ireland’s most valuable brand after growing by 5% over the last year to a brand value of €2.1 billion on the back of new product innovations and steady sales of the world-famous draught, according to the latest report by Brand Finance, the world’s leading independent brand valuation and strategy consultancy. Guinness’s brand value has [...]...
  • Dún Laoghaire-Rathdown County Council Provides Over €742 Million For Future Development Dún Laoghaire-Rathdown County Council has agreed a Capital Expenditure Programme of over €742 million. The Three Year Capital Programme 2018-2020 will deliver a considerable number of infrastructural and housing projects that are of strategic importance to the County and the Region from both a social and an economic perspective. This will shape the development of [...]...

Dublin startup scores €85 million funding for new approach to cancer therapy

Dublin startup scores €85 million funding for new approach to cancer therapy
October 04
10:07 2016

Carrick Therapeutics, a Dublin-based startup specialising in a unique approach to cancer therapies, has launched having secured $95 (€85) million in funding.

Heavyweight investors have lined up to support the Irish company, with US firm ARCH Venture Partners, leading UK firm Woodford Investment Management and GV (Google Ventures) among those who have provided the capital. Lightstone Ventures, which is supported by Enterprise Ireland and the Irish Strategic Investment Fund, has also support Carrick.

The company will aim to build an innovative portfolio of first-in-class treatments that are advanced through understanding the mechanisms that cause cancer and resistance and tailored to an individual patient’s tumour.

Personalised cancer medicine, which is targeted at that specific patient’s cancer, is seen as a crucial next step in the fight against the disease. Cancer is so difficult to treat because of its unpredictability, but new scientific advances are developing more and more of an understanding about it affects each person.

Carrick Therapeutics has set out a clear vision to target the molecular pathways that drive the most aggressive and resistant forms of cancer in order to have a major impact on the lives of patients. With such large funding, the company will look to develop a portfolio of first-in-class treatments, rather than a single compound or biological mechanism.

Their CEO, Dr Elaine Sullivan, has previously worked as Vice President for Research and Development for pharma giants Eli Lilly and AstraZeneca.

She comments: “Our aim is to build Europe’s leading oncology company. There is a significant unmet need in cancer treatment, and targeting aggressive and resistant disease is an area where we can make a real difference to patients’ lives.”

Sullivan has indicated that Ireland was an ideal choice for their base of operations due to the opportunities for collaboration with clinicians and scientists, and because its skilled workforce makes it a great place for recruitment.

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4